17/09/2021- COVIDRIVE, a long-term, multi-country, hospital-based study investigating the effectiveness of COVID-19 vaccines across Europe has recently begun with the successful recruitment of its first patient – at a site in Valencia (Spain).
COVIDRIVE consists of a unique, cross-pharma consortium of vaccine companies and research groups who are joining forces to collect real-world data on the effectiveness of COVID-19 vaccines. This first COVIDRIVE study will monitor for variants of concern and help provide answers to the critical questions relating to COVID-19 vaccine effectiveness, including duration of protection of the different vaccines, impact of additional vaccine doses and different vaccine combinations.
